CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in CNS Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +7 vs. Q3 2024
- Shares held
- 2.47M
- +1.90M (+329.1%) vs. Q3 2024
- Total value
- $297.3K
- +$222.1K (+295.1%) vs. Q3 2024
- New holders
- 10
- 5 more added
- Sold out
- 3
- 2 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNSP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 11 | $1.34M |
| Q1 2026 | 12 | $348.7K |
| Q4 2025 | 10 | $652.4K |
| Q3 2025 | 8 | $221.5K |
| Q2 2025 | 11 | $421.8K |
| Q1 2025 | 7 | $55.2K |
| Q4 2024 | 21 | $297.3K |
| Q3 2024 | 14 | $75.3K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 19 | $351.0K |
| Q4 2023 | 16 | $425.3K |
| Q3 2023 | 12 | $131.7K |
| Q2 2023 | 12 | $234.4K |
| Q1 2023 | 13 | $190.5K |
| Q4 2022 | 10 | $335.0K |
| Q3 2022 | 21 | $232.0K |
| Q2 2022 | 23 | $343.5K |
| Q1 2022 | 20 | $589.0K |
| Q4 2021 | 24 | $828.0K |
| Q3 2021 | 20 | $1.44M |
| Q2 2021 | 20 | $2.64M |
| Q1 2021 | 19 | $3.04M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding CNS Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 419,737 | $50.5K | 0.00% | +396,577+1,712.3% | Added |
| Geode Capital Management, LLC | 387,064 | $46.6K | 0.00% | +183,884+90.5% | Added |
| Citadel Advisors LLC | 321,874 | $38.8K | 0.00% | +321,874 | New |
| XTX Topco Ltd | 294,919 | $35.5K | 0.00% | +294,919 | New |
| Connective Capital Management, LLC | 280,055 | $33.7K | 0.04% | +280,055 | New |
| Integrated Wealth Concepts LLC | 250,000 | $30.1K | 0.00% | +250,000 | New |
| Virtu Financial LLC | 162,349 | $20.0K | 0.00% | +39,473+32.1% | Added |
| HRT Financial LP | 156,007 | $18.0K | 0.00% | +156,007 | New |
| Two Sigma Investments, LP | 93,077 | $11.2K | 0.00% | +93,077 | New |
| UBS Group AG | 64,418 | $7.73K | 0.00% | −117,448−64.6% | Reduced |
| Goldman Sachs Group Inc | 40,329 | $4.86K | 0.00% | +12,132+43.0% | Added |
| MAI Capital Management | 2,000 | $241 | 0.00% | +2,000 | New |
| Bank of America Corp | 440 | $53 | 0.00% | +206+88.0% | Added |
| SBI Securities Co., Ltd. | 105 | $13 | 0.00% | +105 | New |
| Synergy Investment Management, LLC | 9 | $1 | 0.00% | +9 | New |
| Wells Fargo & Company | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 1 | $0 | 0.00% | −1−50.0% | Reduced |
| Dogwood Wealth Management LLC | 1 | $0 | 0.00% | +1 | New |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −16,298−100.0% | Sold out |
| Aspire Private Capital, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |